posted on 2016-01-25, 00:00authored byDavid
P. Cowcher, Tanja Deckert-Gaudig, Victoria L. Brewster, Lorna Ashton, Volker Deckert, Royston Goodacre
The correct glycosylation of biopharmaceutical
glycoproteins and
their formulations is essential for them to have the desired therapeutic
effect on the patient. It has recently been shown that Raman spectroscopy
can be used to quantify the proportion of glycosylated protein from
mixtures of native and glycosylated forms of bovine pancreatic ribonuclease
(RNase). Here we show the first steps toward not only the detection
of glycosylation status but the characterization of glycans themselves
from just a few protein molecules at a time using tip-enhanced Raman
scattering (TERS). While this technique generates complex data that
are very dependent on the protein orientation, with the careful development
of combined data preprocessing, univariate and multivariate analysis
techniques, we have shown that we can distinguish between the native
and glycosylated forms of RNase. Many glycoproteins contain populations
of subtly different glycoforms; therefore, with stricter orientation
control, we believe this has the potential to lead to further glycan
characterization using TERS, which would have use in biopharmaceutical
synthesis and formulation research.